Check out our most popular compounded medications! Get Started
Estriol 1 mg/Mannose (D) 150 mg Capsules (Vet) are solid dosage forms composed of two gelatin or vegetarian shells. These capsules enclose a precise dosage of Estriol and D-Mannose, which are used to treat conditions such as urinary incontinence, cystitis, urogenital atrophy, vaginal dryness, and dysuria in animals. The design of these capsules allows for convenient administration and easy swallowing.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Estriol 1 mg/Mannose (D) 150 mg Capsules (Vet) is a specially compounded medication designed to address a range of conditions associated with the urinary and reproductive systems. This formulation combines the therapeutic benefits of Estriol, a form of estrogen, and Mannose (D), a sugar molecule, to provide relief from symptoms such as urinary incontinence, urogenital atrophy, vaginal dryness, dysuria, and vulvovaginal pruritus.
Estriol, as a form of estrogen, plays a crucial role in regulating the female reproductive system. It works by boosting the body's estrogen production, which in turn helps alleviate symptoms of urinary incontinence, urogenital atrophy, and vaginal dryness. On the other hand, Mannose (D) is known for its anti-inflammatory properties and its ability to enhance the body's nutrient absorption process. This can help reduce symptoms of dysuria and vulvovaginal pruritus.
The medication is encapsulated in two gelatin or vegetarian shells, providing a solid dosage form that is easy to swallow and ensures a precise dosage of the active ingredients.
It is important to remember that this compounded medication should be used strictly under the guidance of a healthcare professional. If you have any queries or concerns about this formulation, please do not hesitate to contact us at Bayview Pharmacy. We are committed to providing comprehensive information and support to ensure the best possible outcomes for our patients.
This compounded formulation of Estriol 1 mg/Mannose (D) 150 mg Capsules (Vet) is a solid dosage form, designed for easy swallowing and precise dosage delivery. It is primarily used in the treatment of urinary incontinence, urogenital atrophy, vaginal dryness, dysuria, and vulvovaginal pruritus in veterinary applications.
Estriol, a form of estrogen, is instrumental in alleviating symptoms associated with urinary incontinence, urogenital atrophy, and vaginal dryness.
It is important to note that this formulation is not recommended for use in pregnant or lactating animals. It is crucial to administer this medication as directed and monitor for any adverse reactions. Any observed adverse reactions should be promptly reported to the healthcare provider.
Activities that may increase the risk of bleeding, such as contact sports or heavy lifting, should be avoided while the animal is on this medication. Caution is also advised when this formulation is administered in conjunction with other medications, as potential drug interactions may occur.
For any further queries or concerns regarding this formulation, please do not hesitate to reach out to us. We are committed to providing comprehensive information to ensure the safe and appropriate use of our compounded formulations.
Estriol 1 mg/Mannose (D) 150 mg Capsules (Vet) is a specially compounded medication designed to address a range of conditions associated with the urinary and reproductive systems. This formulation combines the therapeutic benefits of Estriol, a form of estrogen, and Mannose (D), a sugar molecule, to provide relief from symptoms such as urinary incontinence, urogenital atrophy, vaginal dryness, dysuria, and vulvovaginal pruritus.
Estriol, a hormone integral to the female reproductive system, works by enhancing the strength of bladder muscles and improving the body's capacity to store urine, thereby alleviating symptoms of urinary incontinence. It also stimulates the production of collagen and elastin, which enhances the elasticity of the vaginal walls and helps combat urogenital atrophy. Furthermore, Estriol aids in the production of natural lubricants, helping to alleviate vaginal dryness.
Mannose (D) complements the action of Estriol by reducing inflammation and enhancing the body's ability to absorb Estriol. This dual action helps to alleviate symptoms of dysuria, characterized by a burning sensation during urination, and vulvovaginal pruritus, which manifests as itching and irritation of the vulva and vagina.
Estriol 1 mg/Mannose (D) 150 mg Capsules (Vet) is a appropriate treatment option for a variety of conditions related to the urinary and reproductive systems. For any queries or concerns regarding this formulation, please feel free to reach out.
The compounded formulation of Estriol 1 mg/Mannose (D) 150 mg Capsules (Vet) is a solid dosage form composed of two gelatin or vegetarian shells that enclose the medication. This design allows for convenient and easy swallowing, and provides a precise dosage of the active ingredients. This formulation may be used to treat a variety of conditions.
One of the primary uses of this formulation is to treat recurrent urinary tract infections. It may also be beneficial for conditions such as interstitial cystitis and vulvovaginal candidiasis. The Estriol component of this formulation may help reduce the risk of recurrent urinary tract infections in postmenopausal women.
Another potential use of this formulation is to alleviate the symptoms of vulvovaginal atrophy, which can include vaginal dryness, itching, and burning.
While this formulation is primarily used in veterinary medicine, it may also have potential applications in human medicine.
This is a compounded formulation of Estriol and D-Mannose in a solid dosage form. It is composed of two gelatin or vegetarian shells that enclose the medication, allowing for convenient and easy swallowing, and providing a precise dosage of the active ingredients.
The two shells, which can be made of gelatin or a vegetarian alternative, serve to enclose the medication. This design allows for easy swallowing and ensures that the patient receives a precise dosage of the active ingredients.
The active ingredients in this medication are Estriol, a form of estrogen, and D-Mannose, a type of sugar molecule.
Yes, this medication can be suitable for vegetarians if the shells are made from a vegetarian alternative to gelatin. It's best to confirm with your pharmacist or healthcare provider.
The medication is enclosed within two shells, which ensures that each capsule contains an exact amount of the active ingredients, providing a precise dosage.
The solid dosage form allows for easy swallowing and ensures that the patient receives a precise dosage of the active ingredients. It also provides a convenient way to take the medication.
Yes, the design of the capsule, enclosed in two shells, allows for easy and convenient swallowing.
Yes, this medication is a veterinary formulation, which means it is designed for use in animals. However, it should only be administered under the guidance of a veterinarian.
Each capsule contains 1 mg of Estriol and 150 mg of D-Mannose.
D-Mannose is a type of sugar molecule that is used in this medication. It is often used in veterinary medicine for its potential benefits in urinary tract health.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
